Novartis AG guess massive on its new cholesterol-busting drug. To beat the tough market for new coronary heart medicines, it’s pursuing an unconventional technique that turns the normal drug launch on its head.
Slightly than looking for to seize the eye of sufferers and profitable assist from particular person physicians, the Swiss pharmaceutical large is specializing in the individuals who run giant hospital techniques. Its pitch: A big-scale rollout of the drug, known as Leqvio, might avert 1000’s of coronary heart assaults and strokes.
Novartis Rethinks Sales Strategy for New Cholesterol Drug Launch Source link Novartis Rethinks Sales Strategy for New Cholesterol Drug Launch